Physician profile
Chad D Chambers
NPI 1730149907
$3,112.47
in general payments reported to CMS, 2019-2025
24 companies · $413 in 2025
The $413 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $171 · 2021: $155 · 2022: $513 · 2023: $411 · 2024: $370 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $530.48 | 2023-2025 | |
| Arthrex, INC. | $526.00 | 2019 | |
| Medwest Associates | $458.00 | 2019 | |
| Smith+Nephew, INC. | $454.51 | 2020-2025 | Grafix Pl, Stravix, Regranex |
| Abbvie INC. | $118.42 | 2022-2023 | Dalvance |
| Paragon 28, INC. | $106.63 | 2020-2022 | |
| Kerecis Limited | $101.12 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Grt US Holding, INC. | $90.51 | 2022 | |
| Bioventus LLC | $87.19 | 2021-2022 | |
| Organogenesis INC. | $82.37 | 2022-2024 | Puraply |
| Averitas Pharma INC. | $78.67 | 2023-2024 | Qutenza |
| Orthofix Medical, INC. | $76.80 | 2019-2025 | Physio-Stim, Spinal-Stim |
| Wright Medical Technology, INC. | $70.64 | 2019 | |
| Convatec INC. | $49.87 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $48.07 | 2020-2024 | Tapestry |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $44.94 | 2022-2023 | Senza |
| Hartmann USA, INC. | $41.37 | 2023 | Zetuvit Plus |
| Linvatec Corporation | $33.86 | 2019-2023 | Biobrace 23mm, Allograft Tissue |
| Inari Medical, INC. | $23.09 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Embody, INC. | $21.72 | 2022 | |
| Paratek Pharmaceuticals, INC. | $20.07 | 2025 | Nuzyra |
| Horizon Therapeutics Plc | $20.02 | 2022 | |
| Integra Lifesciences Corporation | $14.10 | 2020 | |
| Kci USA, INC. | $14.02 | 2023 | Snap, V.A.C. Dermatac, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.